3X ERE TATA luc Citations (46)
Originally described in: The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.Hall JM, McDonnell DP Endocrinology. 1999 Dec . 140(12):5566-78. PubMed Journal
Articles Citing 3X ERE TATA luc
| Articles |
|---|
| Identification and functional characterization of a polymorphic oestrogen response element in the human coagulation factor IX gene promoter. Adams B, Western AK, Winship PR. Br J Haematol. 2008 Jan;140(2):241-9. doi: 10.1111/j.1365-2141.2007.06912.x. PubMed |
| Evolutionary origins of the estrogen signaling system: insights from amphioxus. Callard GV, Tarrant AM, Novillo A, Yacci P, Ciaccia L, Vajda S, Chuang GY, Kozakov D, Greytak SR, Sawyer S, Hoover C, Cotter KA. J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):176-88. doi: 10.1016/j.jsbmb.2011.03.022. Epub 2011 Apr 14. PubMed |
| Activation of southern white rhinoceros (Ceratotherium simum simum) estrogen receptors by phytoestrogens: potential role in the reproductive failure of captive-born females? Tubbs C, Hartig P, Cardon M, Varga N, Milnes M. Endocrinology. 2012 Mar;153(3):1444-52. doi: 10.1210/en.2011-1962. Epub 2012 Jan 17. PubMed |
| Estrogenic effect of three substituted deoxybenzoins. Chandrasekharan S, Bhaskar B, Muthiah R, Chandrasekharan AK, Ramamurthy V. Steroids. 2013 Feb;78(2):147-55. doi: 10.1016/j.steroids.2012.11.007. Epub 2012 Nov 23. PubMed |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA, Hudis C, Chen D, Taran T, Hortobagyi G, Greene G, Berger M, Baselga J, Chandarlapaty S.
Nat Genet. 2013 Dec;45(12):1439-45. doi: 10.1038/ng.2822. Epub 2013 Nov 3.
PubMed
Associated Plasmids |
| Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events. Svard J, Blanco F, Nevin D, Fayne D, Mulcahy F, Hennessy M, Spiers JP. Br J Pharmacol. 2014 Jan;171(2):480-97. doi: 10.1111/bph.12480. PubMed |
| In search of novel drug target sites on estrogen receptors using RNA aptamers. Xu D, Chatakonda VK, Kourtidis A, Conklin DS, Shi H. Nucleic Acid Ther. 2014 Jun;24(3):226-38. doi: 10.1089/nat.2013.0474. Epub 2014 Mar 3. PubMed |
| Topical KGF treatment as a therapeutic strategy for vaginal atrophy in a model of ovariectomized mice. Ceccarelli S, D'Amici S, Vescarelli E, Coluccio P, Matricardi P, di Gioia C, Benedetti Panici P, Romano F, Frati L, Angeloni A, Marchese C. J Cell Mol Med. 2014 Sep;18(9):1895-907. doi: 10.1111/jcmm.12334. Epub 2014 Aug 1. PubMed |
| In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor alpha. Singh K, Munuganti RS, Leblanc E, Lin YL, Leung E, Lallous N, Butler M, Cherkasov A, Rennie PS. Breast Cancer Res. 2015 Feb 25;17:27. doi: 10.1186/s13058-015-0529-8. PubMed |
| Identification of California Condor Estrogen Receptors 1 and 2 and Their Activation by Endocrine Disrupting Chemicals. Felton RG, Steiner CC, Durrant BS, Keisler DH, Milnes MR, Tubbs CW. Endocrinology. 2015 Dec;156(12):4448-57. doi: 10.1210/en.2015-1448. Epub 2015 Sep 15. PubMed |
| Adaptive Significance of ERalpha Splice Variants in Killifish (Fundulus heteroclitus) Resident in an Estrogenic Environment. Cotter KA, Nacci D, Champlin D, Yeo AT, Gilmore TD, Callard GV. Endocrinology. 2016 Jun;157(6):2294-308. doi: 10.1210/en.2016-1052. Epub 2016 Apr 12. PubMed |
| Estrogenicity of captive southern white rhinoceros diets and their association with fertility. Tubbs CW, Moley LA, Ivy JA, Metrione LC, LaClaire S, Felton RG, Durrant BS, Milnes MR. Gen Comp Endocrinol. 2016 May 7. pii: S0016-6480(16)30123-X. doi: 10.1016/j.ygcen.2016.05.004. PubMed |
| Drug Repurposing Screening Identifies Novel Compounds That Effectively Inhibit Toxoplasma gondii Growth. Dittmar AJ, Drozda AA, Blader IJ. mSphere. 2016 Mar 2;1(2). pii: e00042-15. doi: 10.1128/mSphere.00042-15. eCollection 2016 Mar-Apr. PubMed |
| Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases. Sommer AK, Hermawan A, Mickler FM, Ljepoja B, Knyazev P, Brauchle C, Ullrich A, Wagner E, Roidl A. Oncotarget. 2016 Aug 2;7(31):50461-50476. doi: 10.18632/oncotarget.10459. PubMed |
| Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease. Besse-Patin A, Leveille M, Oropeza D, Nguyen BN, Prat A, Estall JL. Gastroenterology. 2017 Jan;152(1):243-256. doi: 10.1053/j.gastro.2016.09.017. Epub 2016 Sep 20. PubMed |
| Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals. Huang J, Woods P, Normolle D, Goff JP, Benos PV, Stehle CJ, Steinman RA. Breast Cancer Res Treat. 2017 Jan;161(2):229-243. doi: 10.1007/s10549-016-4052-0. Epub 2016 Nov 16. PubMed |
| Evaluation of Estrogenic Activity of Extract from the Herbal Mixture Cynanchum wilfordii Hemsley, Phlomis umbrosa Turczaninow, and Angelica gigas Nakai. Kim SJ, Jin SW, Lee GH, Kim YA, Jeong HG. Toxicol Res. 2017 Jan;33(1):71-77. doi: 10.5487/TR.2017.33.1.071. Epub 2017 Jan 15. PubMed |
| Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERalpha). Pham DH, Tan CC, Homan CC, Kolc KL, Corbett MA, McAninch D, Fox AH, Thomas PQ, Kumar R, Gecz J. Hum Mol Genet. 2017 Jun 1;26(11):2042-2052. doi: 10.1093/hmg/ddx094. PubMed |
| DEFINING THE ROLE OF ESTROGEN RECEPTOR BETA IN THE REGULATION OF FEMALE FERTILITY. Rumi MK, Singh P, Roby KF, Zhao X, Iqbal K, Ratri A, Lei T, Cui W, Borosha S, Dhakal P, Kubota K, Chakraborty D, Vivian JL, Wolfe MW, Soares MJ. Endocrinology. 2017 May 16. doi: 10.1210/en.2016-1916. PubMed |
| Modulation of estrogen related receptor alpha activity by the kinesin KIF17. Seneviratne AMPB, Turan Z, Hermant A, Lecine P, Smith WO, Borg JP, Jaulin F, Kreitzer G. Oncotarget. 2017 May 23. doi: 10.18632/oncotarget.18104. PubMed |
| Modulation of estrogen related receptor alpha activity by the kinesin KIF17. Seneviratne APB, Turan Z, Hermant A, Lecine P, Smith WO, Borg JP, Jaulin F, Kreitzer G. Oncotarget. 2017 May 23;8(31):50359-50375. doi: 10.18632/oncotarget.18104. eCollection 2017 Aug 1. PubMed |
| Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes. Jia S, Miedel MT, Ngo M, Hessenius R, Chen N, Wang P, Bahreini A, Li Z, Ding Z, Shun TY, Zuckerman DM, Taylor DL, Puhalla SL, Lee AV, Oesterreich S, Stern AM. Oncology. 2018;94(3):176-189. doi: 10.1159/000485510. Epub 2018 Jan 6. PubMed |
| Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-alpha in Hormone-Resistant Breast Cancers. Singh K, Munuganti RSN, Lallous N, Dalal K, Yoon JS, Sharma A, Yamazaki T, Cherkasov A, Rennie PS. Int J Mol Sci. 2018 Feb 15;19(2). pii: ijms19020579. doi: 10.3390/ijms19020579. PubMed |
| SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment. Huang YH, Chu PY, Chen JL, Huang CT, Lee CH, Lau KY, Wang WL, Wang YL, Lien PJ, Tseng LM, Liu CY. J Clin Med. 2018 Aug 28;7(9). pii: jcm7090245. doi: 10.3390/jcm7090245. PubMed |
| Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. Bielski CM, Donoghue MTA, Gadiya M, Hanrahan AJ, Won HH, Chang MT, Jonsson P, Penson AV, Gorelick A, Harris C, Schram AM, Syed A, Zehir A, Chapman PB, Hyman DM, Solit DB, Shannon K, Chandarlapaty S, Berger MF, Taylor BS. Cancer Cell. 2018 Nov 12;34(5):852-862.e4. doi: 10.1016/j.ccell.2018.10.003. Epub 2018 Nov 1. PubMed |
| MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators. Ljepoja B, Garcia-Roman J, Sommer AK, Wagner E, Roidl A. Breast. 2019 Feb;43:31-38. doi: 10.1016/j.breast.2018.10.007. Epub 2018 Oct 18. PubMed |
| Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells. Hannafon BN, Gin AL, Xu YF, Bruns M, Calloway CL, Ding WQ. Cell Commun Signal. 2019 Feb 19;17(1):13. doi: 10.1186/s12964-019-0325-7. PubMed |
| The effects of bisphenol A, benzyl butyl phthalate, and di(2-ethylhexyl) phthalate on estrogen receptor alpha in estrogen receptor-positive cells under hypoxia. Park C, Lee J, Kong B, Park J, Song H, Choi K, Guon T, Lee Y. Environ Pollut. 2019 May;248:774-781. doi: 10.1016/j.envpol.2019.02.069. Epub 2019 Feb 21. PubMed |
| Ginsenoside Rf inhibits cyclooxygenase-2 induction via peroxisome proliferator-activated receptor gamma in A549 cells. Song H, Park J, Choi K, Lee J, Chen J, Park HJ, Yu BI, Iida M, Rhyu MR, Lee Y. J Ginseng Res. 2019 Apr;43(2):319-325. doi: 10.1016/j.jgr.2018.11.007. Epub 2018 Nov 30. PubMed |
| Nuclear estrogen receptor activation by insulin-like growth factor-1 in Neuro-2A neuroblastoma cells requires endogenous estrogen synthesis and is mediated by mutually repressive MAPK and PI3K cascades. Pollard KJ, Daniel JM. Mol Cell Endocrinol. 2019 Jun 15;490:68-79. doi: 10.1016/j.mce.2019.04.007. Epub 2019 Apr 13. PubMed |
| A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer. Yang Z, Wang D, Johnson JK, Pascal LE, Takubo K, Avula R, Chakka AB, Zhou J, Chen W, Zhong M, Song Q, Ding H, Wu Z, Chandran UR, Maskrey TS, Nelson JB, Wipf P, Wang Z. Mol Cancer Ther. 2020 Jan;19(1):75-88. doi: 10.1158/1535-7163.MCT-19-0489. Epub 2019 Sep 25. PubMed |
| Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L. EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28. PubMed |
| Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor alpha. Zinovkina LA, Galivondzhyan AK, Prikhodko AS, Galkin II, Zinovkin RA. PeerJ. 2020 Mar 25;8:e8803. doi: 10.7717/peerj.8803. eCollection 2020. PubMed |
| Globular adiponectin antagonizes leptin-induced growth of cancer cells by modulating inflammasomes activation: Critical role of HO-1 signaling. Raut PK, Park PH. Biochem Pharmacol. 2020 Oct;180:114186. doi: 10.1016/j.bcp.2020.114186. Epub 2020 Jul 31. PubMed |
| The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERalpha to inhibit the growth of breast cancer induced by oestrogen. Zhang N, Sun P, Xu Y, Li H, Liu H, Wang L, Cao Y, Zhou K, TinghuaiWang. Cancer Lett. 2021 Feb 1;498:54-69. doi: 10.1016/j.canlet.2020.10.019. Epub 2020 Oct 15. PubMed |
| XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation. Barua D, Abbasi B, Gupta A, Gupta S. Heliyon. 2020 Oct 10;6(10):e05217. doi: 10.1016/j.heliyon.2020.e05217. eCollection 2020 Oct. PubMed |
| Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERalpha) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. Waddell A, Mahmud I, Ding H, Huo Z, Liao D. Cancers (Basel). 2021 Jun 4;13(11). pii: cancers13112799. doi: 10.3390/cancers13112799. PubMed |
| Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma. Pratap UP, Sareddy GR, Liu Z, Venkata PP, Liu J, Tang W, Altwegg KA, Ebrahimi B, Li X, Tekmal RR, Viswanadhapalli S, McHardy S, Brenner AJ, Vadlamudi RK. Neurooncol Adv. 2021 Jul 17;3(1):vdab099. doi: 10.1093/noajnl/vdab099. eCollection 2021 Jan-Dec. PubMed |
| A-Kinase Anchoring Protein 2 Promotes Protection against Myocardial Infarction. Maric D, Paterek A, Delaunay M, Lopez IP, Arambasic M, Diviani D. Cells. 2021 Oct 23;10(11). pii: cells10112861. doi: 10.3390/cells10112861. PubMed |
| Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Tsoi H, Shi L, Leung MH, Man EPS, So ZQ, Chan WL, Khoo US. Life (Basel). 2022 Jan 10;12(1). pii: life12010093. doi: 10.3390/life12010093. PubMed |
| Fermented Oyster (Crassostrea gigas) Extract Cures and Prevents Prednisolone-Induced Bone Resorption by Activating Osteoblast Differentiation. Molagoda IMN, Athapaththu AMGK, Park EK, Choi YH, Jeon YJ, Kim GY. Foods. 2022 Feb 25;11(5):678. doi: 10.3390/foods11050678. PubMed |
| Assessing Marine Endocrine-Disrupting Chemicals in the Critically Endangered California Condor: Implications for Reintroduction to Coastal Environments. Stack ME, Cossaboon JM, Tubbs CW, Vilchis LI, Felton RG, Johnson JL, Danil K, Heckel G, Hoh E, Dodder NG. Environ Sci Technol. 2022 Jun 21;56(12):7800-7809. doi: 10.1021/acs.est.1c07302. Epub 2022 May 17. PubMed |
| Kinesins Modify ERR1-Dependent Transcription Using a Conserved Nuclear Receptor Box Motif. Seneviratne AMPB, Lidagoster S, Valbuena-Castor S, Lashley K, Saha S, Alimova A, Kreitzer G. Int J Mol Sci. 2023 Feb 14;24(4):3795. doi: 10.3390/ijms24043795. PubMed |
| The Role of NLRP3 in Regulation of Antimicrobial Peptides and Estrogen Signaling in UPEC-Infected Bladder Epithelial Cells. Lindblad A, Wu R, Persson K, Demirel I. Cells. 2023 Sep 18;12(18):2298. doi: 10.3390/cells12182298. PubMed |
| Novel Estrogen Receptor Dimerization BRET-Based Biosensors for Screening Estrogenic Endocrine-Disrupting Chemicals. Choi G, Kang H, Suh JS, Lee H, Han K, Yoo G, Jo H, Shin YM, Kim TJ, Youn B. Biomater Res. 2024 Mar 7;28:0010. doi: 10.34133/bmr.0010. eCollection 2024. PubMed |
| Small molecule conjugates with selective estrogen receptor beta agonism promote anti-aging benefits in metabolism and skin recovery. Zahr T, Boda VK, Ge J, Yu L, Wu Z, Que J, Li W, Qiang L. Acta Pharm Sin B. 2024 May;14(5):2137-2152. doi: 10.1016/j.apsb.2024.01.014. Epub 2024 Jan 29. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.